Ketamin in Anästhesie und Intensivmedizin DOI

Sabine Himmelseher,

Christine H. Meyer‐Frießem

Springer Reference Medizin, Год журнала: 2024, Номер unknown, С. 1 - 13

Опубликована: Дек. 20, 2024

Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions DOI Creative Commons
Kenji Hashimoto, Mingming Zhao, Tingting Zhu

и другие.

Journal of Anesthesia and Translational Medicine, Год журнала: 2024, Номер 3(3), С. 65 - 75

Опубликована: Июль 11, 2024

Ketamine, a dissociative anesthetic, is widely utilized in both human and veterinary anesthesia. Its (S)-enantiomer, esketamine, similarly employed for anesthesia analgesia. The anesthetic effects of ketamine esketamine arise from their antagonism the N-methyl-D-aspartate receptor (NMDAR). In field psychiatry, rapid-acting antidepressant properties severe depression have generated significant interest, resulting its increased off-label usage United States (U.S.). 2019, nasal spray received approval use U.S. Europe. However, concerns emerged regarding potential adverse effects, including long-term efficacy, addiction risks, suicide risk clinical settings. contrast, arketamine, (R)-enantiomer ketamine, exhibits superior longer-lasting rodent models depression, with fewer side compared to esketamine. Nevertheless, research on efficacy safety arketamine patients remains limited. This article provides concise exploration historical two enantiomers while also delving into future directions application these fields.

Язык: Английский

Процитировано

11

Effect of Low-dose Ketamine Infusion on Opioid Consumption in Children Undergoing Open Cardiac Surgery: A Randomized Controlled Double-Blind Study DOI

Mahmoud Abdelfattah,

Ibrahim Abdelbaser, Karim Awad

и другие.

Journal of Cardiothoracic and Vascular Anesthesia, Год журнала: 2024, Номер 38(10), С. 2349 - 2355

Опубликована: Апрель 24, 2024

Язык: Английский

Процитировано

3

Progress in the Clinical Application of Esketamine DOI

宇 乔

Advances in Clinical Medicine, Год журнала: 2024, Номер 14(10), С. 1592 - 1599

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0

Effect of esketamine on reducing postpartum pain and depression DOI
Brandon Lucke‐Wold, Armin Karamian

World Journal of Clinical Cases, Год журнала: 2024, Номер 13(7)

Опубликована: Ноя. 24, 2024

In this editorial, we comment on a recent article by Chen et al, that addressed the effect of intraoperative injection esketamine postoperative analgesia and rehabilitation after cesarean section. Poor management post-cesarean pain is associated with decreased maternal care for baby, longer hospitalization, higher risk developing postpartum depression. Esketamine more potent S-enantiomer ketamine which has shown promising analgesic antidepressant properties managing depression in clinical studies. However, due to its potential adverse effects neurological hemodynamic status patients, it recommended usage low doses should be limited candidates experiencing unbearable pain. Before any recommendation routine perioperative use esketamine, standardized trials are needed strengthen our existing knowledge effectiveness reducing

Язык: Английский

Процитировано

0

Pretreatment with Esketamine Reduces Etomidate-Induced Myoclonus During the Induction of Anesthesia: A Randomized Controlled Trial DOI Creative Commons
J.-Y Wang, Mengmeng Zhu, Yuanyuan Cao

и другие.

Therapeutics and Clinical Risk Management, Год журнала: 2024, Номер Volume 20, С. 829 - 836

Опубликована: Дек. 1, 2024

Myoclonus is a common problem during induction of anesthesia with etomidate. A variety agents, including opioids and lidocaine, reduced the incidence myoclonus. However, there no reported literature evaluating effect esketamine pretreatment on etomidate-induced We investigated influence

Язык: Английский

Процитировано

0

Ketamin in Anästhesie und Intensivmedizin DOI

Sabine Himmelseher,

Christine H. Meyer‐Frießem

Springer Reference Medizin, Год журнала: 2024, Номер unknown, С. 1 - 13

Опубликована: Дек. 20, 2024

Процитировано

0